Seeking Alpha

Oncolytics Biotech (ONCY -1.5%) dips after closing out its previously announced underwritten...

Oncolytics Biotech (ONCY -1.5%) dips after closing out its previously announced underwritten public offering of 8M shares at $4.  The company intends to use the net proceeds from the offering to fund its clinical trial and manufacturing program.
From other sites
Comments (1)
  • TruffelPig
    , contributor
    Comments (4097) | Send Message
     
    Many biotech companies dipped today - I do not see any relationship between the two events.
    25 Feb 2013, 12:42 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs